| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |